Paul H. Klingenstein - Jun 10, 2021 Form 4 Insider Report for Clovis Oncology, Inc. (CLVS)

Role
Director
Signature
/s/ Paul H. Klingenstein
Stock symbol
CLVS
Transactions as of
Jun 10, 2021
Transactions value $
$0
Form type
4
Date filed
6/11/2021, 09:05 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLVS Stock Option (right to buy) Award $0 +42.2K $0.00 42.2K Jun 10, 2021 Common Stock 42.2K $5.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest on the one-year anniversary of the date of grant.